AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israel loses $1 billion Apache deal after failing to find $288 million in funding
2
U.S. Army deploys Elbit's Iron Fist defense system against missiles and drones
3
Israeli startup raises $5 million to rethink one of surgery's most invasive procedures
4
Israel to end private recruitment of construction workers from India and Sri Lanka
5
“We had to accept reality”: At-Bay CEO on the $575 million Munich Re sale
More news

FSD Pharma

3 stories about FSD Pharma
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma’s Acquisition of Therapix Hits a Snag

12.12.18|Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed

28.11.18|Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases